StratifAI
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $13M
Investors
- 8
About StratifAI
Founded in 2023, StratifAI GmbH is dedicated to developing cutting-edge diagnostic tools in oncology.StratifAI specializes in precision oncology through its innovative biomarker platform, Polaris™, which integrates histology, RNASeq, and patient outcomes to provide comprehensive insights into spatial biology. The flagship product, Polaris™ Breast, assesses the metastatic risk in early breast cancer by analyzing digitized histology slides, aiding the refinement of adjuvant treatment options. This diagnostic tool has been scientifically validated on a substantial cohort of over 6,000 patients, underscoring its reliability in clinical settings.StratifAI generates revenue primarily through partnerships with healthcare institutions and research organizations, focusing on the clinical validation and deployment of its biomarker platform. Revenue transactions occur through research agreements or diagnostic service contracts, allowing clients to access the Polaris™ Breast diagnostic tool.StratifAI GmbH plans to enhance its product line by launching new diagnostic tools aimed at furthering precision oncology, although specific release dates have not been disclosed. The company aims to expand into additional international markets, particularly within the European Union and the United States, as regulatory approvals are finalized., Neulogy Ventures and ARVE Capital.
Who invested in StratifAI
8 investors across 1 round
See all investors in StratifAI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 12, 2025
Amount
$13M
Investors
Questions about StratifAI
Who invested in StratifAI?
StratifAI has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has StratifAI raised?
StratifAI has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did StratifAI last raise money?
StratifAI's most recent round on record is a Seed, in Feb 2025.
What does StratifAI do?
Founded in 2023, StratifAI GmbH is dedicated to developing cutting-edge diagnostic tools in oncology.
Where is StratifAI headquartered?
StratifAI is headquartered in Dresden, Germany.
Which VCs invest in companies like StratifAI?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare it companies at StratifAI's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like StratifAI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.